13/MAR/12
Neuron BioPharma at the International Conference on Alzheimer’s Disease 2012
Representatives of Neuron BioPharma attended the 27th International Conference on Alzheimer’s Disease held in London from 7 to 10 March, during which they continued with their contacts to demonstrate new advances with compound NST0037, a potential treatment against Alzheimer’s disease.
The symposium, organised by the associations Alzheimer’s Disease International (ADI) and Alzheimer’s Society, served as a meeting point for the international scientific community, who were able to find out about the latest developments in the study of the Alzheimer’s disease. The symposium was arranged into parallel sessions and also a series of keynote speeches on new developments in aspects of research into social and health care aimed at raising awareness of the importance of investment in scientific research to advance in the fight against Alzheimer’s disease and dementias and also to support associations of carers and those living with these diseases in achieving their objectives.
|